The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe

Abstract Purpose The study aim was to describe the management strategies used for severe infusion-related reactions (SIRs) and understand the impact of such events in oncology day hospitals in France, Germany, Spain, and the UK. Methods The study was based on qualitative telephone interviews and qua...

Full description

Bibliographic Details
Main Authors: George Kafatos, Sabada Dube, Peter Burdon, Kimberly Lowe, Marjorie Leclerc, Alain Flinois, Gaston Demonty
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-03-01
Series:Drugs - Real World Outcomes
Online Access:https://doi.org/10.1007/s40801-020-00185-9
id doaj-10fbfd220315415aaacb3831b7066455
record_format Article
spelling doaj-10fbfd220315415aaacb3831b70664552021-03-14T12:05:56ZengAdis, Springer HealthcareDrugs - Real World Outcomes2199-11542198-97882020-03-017211913010.1007/s40801-020-00185-9The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in EuropeGeorge Kafatos0Sabada Dube1Peter Burdon2Kimberly Lowe3Marjorie Leclerc4Alain Flinois5Gaston Demonty6Center for Observational Research, Amgen LtdCenter for Observational Research, Amgen LtdEU Medical Affairs, Amgen (Europe) GmbHCenter for Observational Research, Amgen IncRWE/Epi Studies, Kantar HealthRWE/Epi Studies, Kantar HealthMedical Development, AmgenAbstract Purpose The study aim was to describe the management strategies used for severe infusion-related reactions (SIRs) and understand the impact of such events in oncology day hospitals in France, Germany, Spain, and the UK. Methods The study was based on qualitative telephone interviews and quantitative self-completion questionnaires and asked healthcare professionals about the impact of SIRs and consequent actions taken. Results The procedures to prevent and manage SIRs were similar across countries and settings. In all countries, they were part of a larger risk-assessment and adverse events-prevention process. Preventive measures included patient history, risk assessment, pre-medication, and close monitoring of high-risk patients. The management procedures comprised stopping the infusion, triggering of the emergency chain, administering corticosteroids ± antihistamines, and hospitalization if necessary. The recalled SIRs had important consequences to affected patients, healthcare providers, and hospital organizational plans. All affected patients needed to be monitored closely for a prolonged time, thus blocking hospital beds. 44% of patients needed to be hospitalized, 17% needed resuscitation, and one patient died of cardiac arrest immediately after the start of the infusion. Importantly, 82% of patients were not re-challenged with the presumedly SIR-causing regimen or re-challenged in a later line. Conclusion SIRs are unpredictable in nature, may have an extremely rapid onset, and are potentially fatal. Such events have a profound impact on the affected and surrounding patients, the care team and the organizational plan of the day-hospitals. Specific tools to reliably identify high-risk patients and predict the occurrence of events are needed.https://doi.org/10.1007/s40801-020-00185-9
collection DOAJ
language English
format Article
sources DOAJ
author George Kafatos
Sabada Dube
Peter Burdon
Kimberly Lowe
Marjorie Leclerc
Alain Flinois
Gaston Demonty
spellingShingle George Kafatos
Sabada Dube
Peter Burdon
Kimberly Lowe
Marjorie Leclerc
Alain Flinois
Gaston Demonty
The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
Drugs - Real World Outcomes
author_facet George Kafatos
Sabada Dube
Peter Burdon
Kimberly Lowe
Marjorie Leclerc
Alain Flinois
Gaston Demonty
author_sort George Kafatos
title The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
title_short The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
title_full The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
title_fullStr The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
title_full_unstemmed The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
title_sort healthcare professionals’ perspective on impact and actions taken following severe infusion reaction events in oncology centers in europe
publisher Adis, Springer Healthcare
series Drugs - Real World Outcomes
issn 2199-1154
2198-9788
publishDate 2020-03-01
description Abstract Purpose The study aim was to describe the management strategies used for severe infusion-related reactions (SIRs) and understand the impact of such events in oncology day hospitals in France, Germany, Spain, and the UK. Methods The study was based on qualitative telephone interviews and quantitative self-completion questionnaires and asked healthcare professionals about the impact of SIRs and consequent actions taken. Results The procedures to prevent and manage SIRs were similar across countries and settings. In all countries, they were part of a larger risk-assessment and adverse events-prevention process. Preventive measures included patient history, risk assessment, pre-medication, and close monitoring of high-risk patients. The management procedures comprised stopping the infusion, triggering of the emergency chain, administering corticosteroids ± antihistamines, and hospitalization if necessary. The recalled SIRs had important consequences to affected patients, healthcare providers, and hospital organizational plans. All affected patients needed to be monitored closely for a prolonged time, thus blocking hospital beds. 44% of patients needed to be hospitalized, 17% needed resuscitation, and one patient died of cardiac arrest immediately after the start of the infusion. Importantly, 82% of patients were not re-challenged with the presumedly SIR-causing regimen or re-challenged in a later line. Conclusion SIRs are unpredictable in nature, may have an extremely rapid onset, and are potentially fatal. Such events have a profound impact on the affected and surrounding patients, the care team and the organizational plan of the day-hospitals. Specific tools to reliably identify high-risk patients and predict the occurrence of events are needed.
url https://doi.org/10.1007/s40801-020-00185-9
work_keys_str_mv AT georgekafatos thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT sabadadube thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT peterburdon thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT kimberlylowe thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT marjorieleclerc thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT alainflinois thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT gastondemonty thehealthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT georgekafatos healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT sabadadube healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT peterburdon healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT kimberlylowe healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT marjorieleclerc healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT alainflinois healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
AT gastondemonty healthcareprofessionalsperspectiveonimpactandactionstakenfollowingsevereinfusionreactioneventsinoncologycentersineurope
_version_ 1724221510700236800